This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Your saved search

Name of saved search:

Search terms:

Would you like email updates of new search results?

Email: (change)

Frequency:

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2020 Jul;21(7):e341.

doi: 10.1016/S1470-2045(20)30354-5.

No authors listed

Published Erratum

No authors listed. Lancet Oncol. 2020 Jul.

. 2020 Jul;21(7):e341.

doi: 10.1016/S1470-2045(20)30354-5.

No abstract available

Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study.
Lee MS, Ryoo BY, Hsu CH, Numata K, Stein S, Verret W, Hack SP, Spahn J, Liu B, Abdullah H, Wang Y, He AR, Lee KH; GO30140 investigators. Lee MS, et al. Lancet Oncol. 2020 Jun;21(6):808-820. doi: 10.1016/S1470-2045(20)30156-X. Lancet Oncol. 2020. PMID: 32502443 Clinical Trial.